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Management and outcome of metastatic 
melanoma during pregnancy
This study describes the largest series of pregnant women 
with metastatic melanoma. The aim was to investigate the 
therapeutic management together with maternal and fetal 
outcomes in pregnant women with advanced melanoma. 
Twenty-two women with stage III or IV melanoma during 
pregnancy were identified. There was no evidence of neo-
natal metastasis or deformities. Placenta metastasis was 
found in one case. The stage III 2-year survival rate was 
56%, which is close to the one reported out of pregnancy. 
The stage IV 2-year survival rate of 17% was shorter than 
the one reported out of pregnancy (28%); however, most 
of the patients were stage IVM1c and the median survival 
for these patients has been estimated at 4.4 months. It is 
therefore suggested that prognosis of metastatic melanoma 
is not worsened by pregnancy, although larger prospective 
studies are needed. Br J Dermatol 2010; 162: 274–81.
Interleukin-10 secretion from CD14+ 
peripheral blood mononuclear cells is 
downregulated in patients with acne vulgaris
This paper adds to the growing volume of data relating to 
immune responses to Propionibacterium acnes in patients 
with acne compared with controls, focusing on interleukin 
(IL)-10 secretion by peripheral blood mononuclear cells 
(PBMCs). The study demonstrates that IL-10 production by 
PBMCs, in particular CD14+ cells, is significantly lower in 
patients with acne. The ability of CD14 cells from patients 
with acne to phagocytose P. acnes bacteria was also 
observed to be defective but the addition of exogenous 
IL-10 to PBMC cultures restored phagocytic activity. These 
data suggest that acne lesions may develop because of a 
defect in immunosurveillance and highlight a potentially 
important role for IL-10 in regulating the inflammatory 
response to P. acnes within follicles. Br J Dermatol 2010; 
162: 296–303.
Viral DNA detection and RAS mutations  
in actinic keratosis and nonmelanoma  
skin cancers
The purpose of this study was to detect the presence of a 
group of viral DNAs in premalignant and malignant skin 
lesions obtained from nonimmunosuppressed hosts and to 
investigate their relationship with the presence of RAS gene 
mutations. Thirty per cent of skin lesions were positive for 
HPV DNA: 33% of BCCs, 33% of SCCs and 31% of AKs, 
compared with 15% of normal skin samples. Twenty-
three per cent of skin lesions were CMV positive: 40% of 
BCCs, 33% of SCCs and 8% of AKs, whereas the virus was 
not detected in normal skin biopsies. All samples were 
negative for HSV and EBV. H-RAS codon 12 mutation was 
not common (4% for AK, 8% for SCC and 6% for BCC). It 
appears that viral infection and oncogene activation rep-
resent two independent factors in the aetiology of AK and 
nonmelanoma skin cancers in immunocompetent patients. 
Br J Dermatol 2010; 162: 325–31.
Long-term outcome of patients  
with polymyositis ⁄dermatomyositis  
and anti-PM-Scl antibody
The authors report a series of 20 patients with polymyositis 
(PM) or dermatomyositis (DM) who present with positive 
anti-PM-Scl antibodies. 75% had pulmonary involvement, 
20% oesophageal involvement and 15% had an underlying 
malignancy. Interestingly, patients often presented symp-
toms that are usually found in antisynthetase syndrome, 
i.e. ‘mechanics hands’ (n = 2; 10%), Raynaud’s phenom-
enon (n = 8; 40%), arthralgia⁄arthritis (n = 7; 35%) and ILD 
(n = 12; 60%). In this cohort of 20 patients, 10% achieved 
disease remission, 70% improved and 20% had a worsened 
clinical status. Previously anti-PM-Scl antibody-positive 
PM⁄DM syndrome has been considered to be a disease with 
a benign course, but this series suggests that the presence 
of anti-PM-Scl antibody does not confer a good prognosis. 
Br J Dermatol 2010; 162: 337–44.
A study of matrix metalloproteinase 
expression and activity in atopic dermatitis 
using a novel skin wash sampling assay  
for functional biomarker analysis
Harper et al. describe a novel (noninvasive) approach to 
ex vivo evaluation of matrix metalloproteinases (MMPs) in 
atopic dermatitis (AD). Saline wash samples from eczema-
tous and unaffected skin of patients with AD and skin of 
normal controls were analysed for their MMP. AD lesions 
were shown to contain 10- to 24-fold more MMP activity 
than those from normal control skin (P < 0.02) and five-
fold more than those from unaffected AD skin (P < 0.05). 
Gelatin zymography and antibody array analysis revealed 
substantial levels of MMP-8 (neutrophil collagenase) and 
MMP-9 (92-kDa gelatinase) in AD skin wash samples. It is 
concluded that MMPs, in particular MMP-8 and MMP-9, 
are an important potential component of the pathology of 
AD. Br J Dermatol 2010; 162: 397–403.
